Center for Scientific Review; Notice of Closed Meetings, 67772-67773 [2015-27870]
Download as PDF
<![CDATA[
67772
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
The Role of Exosomes in HIV
Neuropathogenesis.
Date: December 4, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR13–280:
Program Project: Cellular Reprogramming,
Pluripotency and Differentiation.
Date: December 7–8, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Elena Smirnova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187,
MSC 7840, Bethesda, MD 20892, 301–435–
1236, smirnove@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 29, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–27983 Filed 11–2–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
Conflict: Neurodevelopmental and
Neurodegenerative Diseases.
Date: December 1, 2015.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Samuel C Edwards, Ph.D.,
IRG CHIEF, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; BioCARS:
Structural Dynamics and Biological
Mechanisms.
Date: December 1–3, 2015.
Time: 5:00 p.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Argonne National Laboratory, 9700
South Cass Avenue, Lemont, IL 60439.
Contact Person: C–L Albert Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146,
MSC 7806, Bethesda, MD 20892, 301–435–
1016, wangca@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: Biomedical Technology Research
Resource for NMR Spectroscopy.
Date: December 1–3, 2015.
Time: 6:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Central Park, 1717
Broadway (54th & Broadway), New York, NY
10019.
Contact Person: Kee Hyang Pyon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, pyonkh2@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: December 3, 2015.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shalanda A Bynum, Ph.D.,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3206,
Bethesda, md 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Methodologies to Enhance Understanding of
HIV Associated Social Determinants.
Date: December 4, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Jose H Guerrier, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 28, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–27933 Filed 11–2–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Rheumatoid
Arthritis and Imaging.
Date: November 20, 2015.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Baljit S Moonga, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7806, Bethesda, MD 20892, 301–435–
1777, moongabs@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Psycho/
Neuropathology, Lifespan Development, and
STEM Education.
Date: November 23, 2015.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John H Newman, Ph.D.,
Scientific Review Officer, Center for
E:\FR\FM\03NON1.SGM
03NON1
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Child Psychopathology and
Developmental Disabilities.
Date: November 30, 2015.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 28, 2015.
Sylvia Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–27870 Filed 11–2–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health, National
Institute on Drug Abuse (NIDA)
Announcement of Requirements and
Registration for ‘‘Addiction Research:
There’s an App for That’’ Challenge
Authority: 15 U.S.C. 3719.
The National Institute on
Drug Abuse (NIDA), one of the
components of the National Institutes of
Health (NIH), announces the Challenge,
‘‘Addiction Research: There’s an App
for that’’. With this Challenge, NIDA
aims to develop novel mobile
applications (apps) for future addiction
research explicitly created on Apple
Inc.’s ResearchKit framework.
ResearchKit is open-source software
which makes it easy for researchers and
developers to create apps for specific
biomedical research questions by
circumventing development of custom
code. Contestants will create the
solicited app for use by addiction
researchers to engage mobile device
users in future society-changing
research.
Judging Period: May 2, 2016 to July
29, 2016.
Winners Announced: August 1, 2016.
FOR FURTHER INFORMATION CONTACT:
Elena Koustova, Ph.D., MBA, Director,
Office of Translational Initiatives and
Program Innovations (OTIPI), NIDA
Challenge Manager, National Institute
on Drug Abuse (NIDA), 6001 Executive
Blvd. Room 4286, MSC 9555 Bethesda,
MD 20892–9555 Phone: (301) 496–8768
Email: elena.koustova@nih.gov.
SUPPLEMENTARY INFORMATION:
The Institute’s Statutory Authority to
Conduct the Challenge. NIDA is
conducting this challenge under the
America Creating Opportunities to
Meaningfully Promote Excellence in
Technology, Education, and Science
(COMPETES) Reauthorization Act of
2010, 15 U.S.C. 3719. This Challenge is
consistent with and advances the
mission of NIDA as described in 42
U.S.C. 285o. The general purpose of
NIDA is to conduct and support
biomedical and behavioral research,
health-services research, research
training, and health-information
dissemination with respect to the
prevention of drug abuse and the
treatment of drug abusers. App
developed as a result of this Challenge
will help NIDA to gain strides in
behavioral addiction research. After
winning apps are selected, NIDA may
announce subsequent funding programs
for a future research study with real
human subjects to engage the widest
possible community of participants—
‘‘citizen scientists.’’ These future
research studies will help researchers to
better understand drug abuse and
addiction.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
Subject of Challenge
The Challenge begins November
3, 2015.
Submission Period: November 3, 2015
to April 29, 2016, 11:59 p.m., ET.
Background: The problem of drug
abuse affects almost every community
and family and yet it remains an
uncomfortable subject for discussion.
Each year, substance abuse causes high
rates of injuries and mortality among
Americans and plays a role in many
major social problems, such as drugged
driving, violence, child abuse, stress,
crime, and problems with employment.
It harms unborn babies, destroys
families, and contributes to
homelessness. The societal burden
caused by substance use disorders
exceeds half a trillion dollars yearly.
This cost to society is greater than other
chronic conditions such as diabetes
($131.7 billion) and cancer ($171.6
billion). NIDA sponsors the majority of
addiction-related scientific research in
the world. NIDA-funded researchers
seek to answer important scientific
questions about the paths people take to
DATES:
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
67773
avoid or to succumb to drug addiction,
about the mechanisms and pathways
involved in substance-use disorders,
and about new tools and techniques for
prevention and treatment.
Because the problems stemming from
drug abuse and addiction affect almost
every community and family to some
degree, NIDA issues this Challenge with
the hope that Contestants will actively
mobilize around the need to know more
about the roots of drug abuse and
addiction. Specifically, NIDA is seeking
to engage communities to envision and
to create an app which will help
advance scientific research in areas of
nicotine, opioids, cannabinoids
(including marijuana),
methamphetamines, and prescription
drug use. The Institute is also interested
in further understanding abstinence and
wellness as it relates to drug addiction.
The causes and consequences of
addiction are multi-faceted, involving
biological, behavioral, social, cultural,
economic, and environmental factors.
These factors likely interact, with no
single factor exerting substantial
independent influence on drug use and
addiction risk. Unfortunately, most
research addresses these factors
separately because it is difficult to
collect data on the large numbers of
participants needed to understand the
multi-factor relationships. However, this
is changing. Mobile technology offers
the capacity to recruit large numbers of
participants, in diverse and distant
places and to collect prospective data on
a broad range of variables as these study
participants go about their daily lives.
This approach has already led to
advances in addiction research. Mobile
assessment has extended to geolocation
and physiological monitoring, with
promising results for predicting and
detecting drug use in the field.
As exciting as these findings have
been, however, the scope of studies and
the types and number of participants
studied have been limited by
researchers’ access to mobile
technology. The problem has been
exacerbated by a gap in communication
between addiction researchers and
software and hardware developers. In
addition, NIDA-sponsored mobile tools
and technologies are often afflicted by a
lack of interoperability and by nonsustainability beyond the grant-funding
period.
Fortunately, those concerns can be
successfully addressed by the inventive
uses of customizable research platforms
developed by the established
informatics technology companies. The
recently unveiled ResearchKit
developed by Apple Inc. is the available
platform designed specifically for
E:\FR\FM\03NON1.SGM
03NON1
]]>Agencies
[Federal Register Volume 80, Number 212 (Tuesday, November 3, 2015)]
[Notices]
[Pages 67772-67773]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-27870]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Rheumatoid Arthritis and Imaging.
Date: November 20, 2015.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Baljit S Moonga, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214, MSC 7806, Bethesda, MD
20892, 301-435-1777, moongabs@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Psycho/Neuropathology, Lifespan Development, and STEM
Education.
Date: November 23, 2015.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John H Newman, Ph.D., Scientific Review Officer,
Center for
[[Page 67773]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 3222, MSC 7808, Bethesda, MD 20892, (301) 435-0628,
newmanjh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Child Psychopathology and Developmental
Disabilities.
Date: November 30, 2015.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Serena Chu, Ph.D., Scientific Review Officer,
BBBP IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD
20892, 301-500-5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 28, 2015.
Sylvia Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-27870 Filed 11-2-15; 8:45 am]
BILLING CODE 4140-01-P
